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α-tocopherol transfer protein (TTP) was previously reported to self-aggregate into 24-meric spheres (α-TTPS) and 
to possess transcytotic potency across mono-layers of human umbilical vein endothelial cells (HUVECs). In this 
work, we describe the characterisation of a functional TTP variant with its vitamer selectivity shifted towards 
γ-tocopherol. The shift was obtained by introducing an alanine to leucine substitution into the substrate-binding 
pocket at position 156 through site directed mutagenesis. We report here the X-ray crystal structure of the 
γ-tocopherol specific particle (γ-TTPS) at 2.24 Å resolution. γ-TTPS features full functionality compared to its 
α-tocopherol specific parent including self-aggregation potency and transcytotic activity in trans-well experi-
ments using primary HUVEC cells. The impact of the A156L mutation on TTP function is quantified in vitro by 
measuring the affinity towards γ-tocopherol through micro-differential scanning calorimetry and by determining 
its ligand-transfer activity. Finally, cell culture experiments using adherently grown HUVEC cells indicate that 
the protomers of γ-TTP, in contrast to α-TTP, do not counteract cytokine-mediated inflammation at a tran-
scriptional level. Our results suggest that the A156L substitution in TTP is fully functional and has the potential to 
pave the way for further experiments towards the understanding of α-tocopherol homeostasis in humans.   
1. Introduction 
Vitamin E is a fat-soluble antioxidant that protects cell membranes 
from oxidative damage [1,2]. In total four tocopherol and four toco-
trienol congeners are distinguished by their prefixes (α-to δ-) and 
recognized to feature vitamin E activity. All vitamin E iso-forms are 
exclusively produced by organisms performing oxygenic photosyn-
thesis. Hence, virtually all vitamin E is initially provided through the 
consumption of plants and seeds [3]. The α-tocopherol isomer is the 
most abundant form of vitamin E in green leaves of many plants [4], 
whereas the γ-tocopherol isomer is mainly found in seeds [5]. Vegetable 
oils such as soybean oil (68%), corn oil (77%) or linseed oil (88%) 
contain higher amounts of γ-tocopherol than α-tocopherol. 
In higher animals as well as in humans vitamin E is absorbed through 
the gut and transferred to the liver via lipo-proteins. Depending on the 
dietary habits of people the isomeric composition of the absorbed 
vitamin E may differ significantly. For example, it is estimated that in 
the US the average amount of consumed γ-tocopherol is ten-fold higher 
than that of α-tocopherol [6]. However, the amount of vitamin E isomers 
found in blood and tissues of humans remains consistent, regardless of 
the nutritional composition of vitamin E and thereby its bio-availability. 
α-tocopherol is the most abundant form of vitamin E [7] found in human 
tissues (80%). Studies on vitamin E metabolism indicate that in vivo 
levels of γ-tocopherol also depend on ω- and/or β-oxidation pathways 
[8]. 
Overall, the evolutionary determinants driving isomeric vitamin E 
selectivity towards α-tocopherol in mammals have not been fully un-
derstood yet. Initially, it was proposed that differences in antioxidant 
potency e.g. of γ-tocopherol [9] compared to α-tocopherol might be 
involved in driving selectivity. However, it is rather unlikely that the 
evolutionary preference for α-tocopherol is solely governed by the rather 
small differences in antioxidant activities in vitro [10]. Another rationale 
has emerged from the observation that the oxidation of a generic 
tocopherol may be associated with a relative increase of cytotoxic 
Michael adducts mostly in the case of isomers other than the α-form 
[11]. 
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Nevertheless, current knowledge indicates that two independent 
processes predominantly govern vitamin E selectivity within the liver. 
Firstly, the metabolic processing of vitamin E [12] and second by the 
preferred sequestration of α-tocopherol over the other congeners by the 
α-tocopherol binding protein(α-TTP) [8,13–15], thus removing it from 
the metabolic degradation process. 
Recent studies in our lab have provided X-ray structural and in silico 
mechanistic evidence that upon binding to α-tocopherol, α-TTP acquires 
the tendency to form spherical nanoparticles composed of 24 α-TTP 
units (α-TTPS) [16,17]. The findings indicate that α-TTPS may promote 
isomer selective delivery of α-tocopherol into barrier protected tissues in 
man. In addition, a functional A156L substitution has been introduced 
into α-TTP by site-directed mutagenesis possessing superior affinity to-
wards γ-tocopherol over α-tocopherol (γ-TTP) [18]. 
Fig. 1. General view of γ-TTP (α-TTP 
A156L) in complex with γ-tocopherol. (A) 
View of the tetracosameric nano-sphere of 
γ-TTPS. (B) Zoom of the binding pocket 
with all its residues visualized; in orange 
are the residues highlighted that form the 
niche around C8 of α-tocopherol in the wild 
type α-TTP. The surface of the binding 
pocket is colored depending its hydropho-
bicity. (For interpretation of the references 
to color in this figure legend, the reader is 
referred to the Web version of this article.)   
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In this study, we have pursued a convergent approach aiming at the 
structural elucidation of tetracosameric γ-TTPS nano-particles featuring 
customized γ-tocopherol specificity through the rational A156L modi-
fication within the binding pocket of the protomer. The comparison of 
γ-TTP bound to γ-tocopherol with native α-TTP bound to α-tocopherol 
provides quantitative biophysical evidence for the in vitro functionality 
of both ligand complexes. We also provide evidence for efficient trans-
cytosis of both tetracosameric particle variants over an endothelial 
layer. 
To complete our study, differential data of the corresponding pro-
tomeric isomer complexes on canonical inflammatory pathways in 
adherent cell culture is presented. It is proposed that the carrier effect of 
protomeric TTP attenuates the cell’s inflammatory processes in de-
pendency of the carried tocopherol itself, not the TTP construct. 
2. Results 
Past computational and experimental data identified the A156L 
mutant of α-TTP as a potential functional γ-TTP [18]. To validate this 
hypothesis, we first characterised structurally the γ-tocopherol-A156L 
mutant complex, demonstrating the occurrence of binding of γ-tocoph-
erol in the native ligand binding site of the protein. 
2.1. Crystal structure of tetracosameric γ-TTP complexed with 
γ-tocopherol 
The A156L mutant was successfully expressed, purified and crystal-
lised in complex with RRR-γ-tocopherol. Using crystallization conditions 
similar to those used for tetracosameric α-TTPS nano-spheres [16], we 
also found γ-TTP assembled in the same supramolecular organization. 
Specifically, the crystals of γ-TTP featured a I432 space group in a cubic 
unit cell of edge a = 168.65 Å. The X-ray diffraction pattern allowed the 
determination of an atomic model of γ-TTP complexed to 
RRR-γ-tocopherol refined to a 2.24 Å resolution (Rwork:Rfree 
18.2%:21.8%, see Table A.5). The asymmetric unit consists of a single 
γ-TTP that includes residues 48 to 278, in complex with one γ-tocoph-
erol molecule. The replacement at position 156 alanine with leucine was 
stable, see Fig. 1B. The atomic model of the tetracosameric assembly of 
γ-TTP was found in its oxidized state with a completely folded C-ter-
minal helix and twelve disulfide bonds at position C80 connecting 
adjacent protomers over the two-fold symmetry axis, Fig. 1A. 
2.1.1. The γ-tocopherol binding site in γ-TTP 
The binding pocket of γ-TTP is, with exception of position 156, 
virtually identical to that of α-TTP. Indeed, the same hydrophobic resi-
dues accommodate γ-tocopherol in the binding pocket. As previously 
reported [19] for the native α-TTP/α-tocopherol complex, several resi-
dues such as S136, S140 and three water molecules surround the 
Fig. 2. (A&B) Real space comparison of the binding pockets of wild type α-TTP complexed to RRR-α-tocopherol and of γ-TTP complexed to RRR-γ-tocopherol, 
respectively. (A) In the binding pocket of α-TTP in complex with α-tocopherol I154 is retracted, in order to create space for the niche surrounding the methyl group 
attached to C2 of α-tocopherol. (B) In contrast, in the binding pocket of γ-TTP bound to RRR-γ-tocopherol the void caused by the missing C8 is filled by L156 
maintaining a similar distance (4.479 Å) to C2 as has A156 in the atomic model of wild type α-TTP (4.498 Å). (C) Schematic analysis (ligplot) of the binding pocket 
between α-TTP and γ-TTP; besides the newly introduced L156 very little discrepancies exist between both the atomic models. 
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chromanol moiety of γ-tocopherol. One water molecule connects the 
phenolic hydroxyl of the ligand to the backbone carbonyl of V182 and 
L189. The U-turn of the prenyl tail is similarly positioned within the 
binding pocket as for α-tocopherol bound to α-TTP, confirming predic-
tion by computational modelling [18]. Fig. 2 shows a schematic com-
parison between the binding pocket of γ-TTP and native α-TTP, 
revealing minor differences between the two. Indeed, the substitution of 
alanine at position 156 by leucine fills the niche formerly formed by 
I194, V191, I154 and L183, so compensating for the void generated by 
the missing methyl group at C2 of chromanol moiety in γ-tocopherol. 
Fig. 2C evidences the new hydrophobic interaction between atom C2 of 
the ligand and L156 in substitution of the interaction between I154 and 
the methyl group of α-tocopherol. This demonstrates the compensatory 
effect of the newly introduced alanine 156 by re-establishing optimal 
distance between γ-tocopherol and the binding pocket surface. Calcu-
lations using the online tool CASTp [20] revealed a reduction of the 
binding pocket volume from an original value of 1034.6 Å3 in α-TTP to 
993.5 Å3 in the γ-TTP mutant. Seemingly due to steric clashes, the 
reduction of the niche formed by residues I194, V191, I154 and L183 
makes the binding of the natively preferred α-tocopherol to the γ-TTP 
mutant energetically unfavourable. 
2.2. Thermodynamics an kinetics of γ-tocopherol binding to γ-TTP 
Quantification of the binding affinity and the exchange kinetic rates 
is critical to asses if the A156L mutant can effectively act as a γ-TTP in 
vitro and in the cell. The monomeric protomer of α-TTP shows high 
binding affinity to its ligand, and it has been associated with inter- 
membrane tocopherol transport activity, as widely reported in the 
literature [21–25]. On the contrary, in the tetracosameric assembly the 
mobile lid helix (residues 198–221), which is responsible for the ligand 
access to its binding site, is closed and sterically locked. This prevents 
TTPS from possessing vitamin E transfer activity. In fact, any physio-
logical role of the tetracosameric assembly is likely associated to car-
diovascular vitamin E transport after sequestration by monomeric units 
in liver cells [16]. For this reasons, the binding affinities and transfer 
rates between engineered γ-TTP and α − ,γ − tocopherol were estimated 
using the monomeric protomers only. 
2.2.1. Determination of the binding affinity 
The binding affinity to γ-tocopherol is critical for the functionality of 
γ-TTP in a physiological context, in particular, its ability to solubilise 
γ-tocoherol from the liver into the systemic circulation of a model or-
ganism. For example, mild AVED mutant such as A120T, and H101Q, 
have similar transfer characteristics for yet markedly lower affinities to 
Table 1 
Thermodynamic parameters from mDSC experiments for the respective samples.  
Sample Tm  ΔHu(Tm) ΔSu(Tm) ΔCp,u  
[K] [kcal 
mol− 1] 
[kcal mol− 1] [kcal mol− 1 
K− 1] 
APO α-TTP 326.54 ±
0.76  
94.13 ±
0.33  
0.29 ± 8.90 ×
10− 4  
2.50 ± 0.28  
APO γ-TTP 327.97 ±
0.06  
86.56 ±
3.56  
0.26 ± 0.01  2.36 ± 0.31  
α-TTP +
α-tocopherol 
341.07 ±
0.06  
150.75 ±
1.90  
0.44 ± 0.01  2.16 ± 0.25  
γ-TTP +
γ-tocopherol 
336.53 ±
0.12  
149.97 ±
5.21  
0.45 ± 0.02  2.06 ± 0.20  
Tocopherols are all in RRR-stereoisomer configuration. All data are denoted as 
averages ± SEM.   
Fig. 3. Scheme of the thermodynamic cycle 
that emphasizes the relation between ligand 
binding and protein unfolding. (A) Classical 
thermodynamic cycle that describes a model 
in which the unfolding of the protein in 
complex does not influence the binding. 
Hence, in this model the ligand stays bound 
to the protein, despite of its structural 
integrity. (B) In this scheme unfolding of the 
protein causes the ligand to disassociate 
from the binding protein and the binding to 
the unfolded state is virtually inexistent 
(ΔGUb = 0). (C) Schematic illustration of 
coupling between the unfolding equilibrium 
KU of the protein and the binding equilib-
rium Kb to the ligand. Increments in thermal 
stability reflect the addition of binding free 
energy ΔGNb to the free energy of the protein 
fold ΔG∘U; the resulting free energy is the 
unfolding free energy ΔGTU of the protein- 
ligand complex.   
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α-tocopherol [26]. 
The determination of the dissociation constant Kd was done by an 
analytical methodology based on micro-differential scanning calorim-
etry (mDSC), which allows the individual estimate of the protein 
unfolding temperature and associated thermodynamic quantities: the 
melting temperature, Tm, and the unfolding enthalpies, entropies at Tm 
(ΔHu(Tm),ΔSu(Tm)) and the change in heat capacity by unfolding 
(ΔCp,u) for the apo and holo states (see SI for details 4.5). Related results 
are presented in Table 1. 
The related unfolding free energies ΔGu(T) were determined using 
the Gibbs-Helmholtz equation (1)) using thermodynamic values from 
the mDSC experiment (Table 1). 
ΔGu(T)=ΔHu
(
1 −
T
Tm
)
− ΔCp,u
[
Tm − T + ln
T
Tm
]
(1) 
The free energy of binding ΔGb(T) is simply obtained from a ther-
modynamic cycle Fig. 3, as the difference between the unfolding free 
energies of the apo- and holo-states: 
ΔGb(T)=ΔGapou (T) − ΔG
holo
u (T) (2) 
and consequently, the dissociation constant Kd: 
Kd = e
ΔGb
RT (3) 
The thermodynamic analysis in this study follows that previously 
reported [18]. In this instance, however, it is applied to compare an apo- 
and a holo-state of the associated protein. The energetic difference be-
tween apo-α-TTP and holo-α-TTP accounts for the absolute binding 
observed. In the previous study, mDSC was used to compare binding of 
α− and γ − tocopherol ligands to the same protein, thus reporting the 
ΔΔG of binding for the two isoforms. The resulting exponential plot for 
Kd as a function of the temperature is shown in Fig. 4. At physiological 
temperature (310.15 K) we calculated a dissociation constant of 14.25 
nM for the native α-TTP + α-tocopherol complex, and of 53.79 nM for 
γ-TTP + γ-tocopherol as shown in Fig. 4B, corresponding to a difference 
of only ̃ 0.8 kcal mol− 1 in binding free energy for the two complexes. 
2.2.2. Thermodynamic analysis of ligand binding 
mDSC experiments allowed not only for the quantification of binding 
free energy, but also for a qualitatively analysis of thermodynamic 
features of the binding event, as illustrated in Fig. 5A. In both cases, the 
major contribution to the binding is enthalpic, as expected for hydro-
phobic substrates (ΔHb = − 30.79 kcal mol− 1 for α-TTP + α-tocopherol 
and ΔHb = − 51.33 kcal mol− 1 for γ-TTP + γ-tocopherol), and for the 
Fig. 4. (A) Gibbs-Helmholtz plots of ΔG∘U 
and ΔGTU as functions of temperature. It can 
be observed that the general stability of 
α-TTP (apoprotein and holoprotein) is quite 
similar to γ-TTP. However, ΔGTU of γ-TTP 
features a strikingly sharper decline than 
that of the wild type. The difference be-
tween both curves at any temperature cor-
responds to ΔGb(T). The fact that ΔGb of 
γ-TTP decreases much faster with increasing 
temperature reflects the lower overall af-
finity of γ-TTP for γ-tocopherol than α-TTP 
for α-tocopherol. (B) Arrhenius plots of the 
dissociation equilibrium (Kd) for α-TTP +
α-tocopherol and γ-TTP + γ-tocopherol, 
respectively. Values for the Kd at 24.85 ∘C 
(298 K) and at 36.85 ∘C (310 K) are high-
lighted within the plots.   
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large network of van der Waals contacts formed between the ligand and 
several amino-acid residues in the binding pocket, see Fig. 5B. The 
entropic contribution ( − TΔSb) is unfavourable at 310 K, (23.83 kcal 
mol− 1 for α-TTP wt + α-tocopherol and 45.28 kcal mol− 1 for γ-TTP +
γ-tocopherol). This is also expected in molecular binding events where 
there is a neat loss in the translational entropy. Interestingly, even 
though the resulting binding free energies at 310 K are very similar, the 
two complexes show clear differences in the two enthalpic and entropic 
components. The reasons for these differences may be related to the 
different volume of the binding pocket, that on the one hand increases 
favorable binding interactions, but one the other hand likely restricts the 
motion of the flexible phytyl tail of the ligand. An increased value of ΔHb 
for γ-TTP is an indication of a stronger temperature dependency of the 
dissociation constant. This may affect the behaviour at body tempera-
ture in a future in vivo experiment compared to in vitro data collected a 
room conditions. 
2.2.3. Characterisation of kinetic rates of γ-TTP 
A functional γ-TTP must show an efficient uptake/release of the 
ligand between its pocket and the environment. To verify that the A156L 
mutation did not affect dramatically such properties, we measured in 
vitro transfer activity and compared those to native α-TTP. Specifically, 
release rates were determined by monitoring the transfer of tocopherol 
from holo-TTP to acceptor liposomes by fluorescence resonance energy 
transfer (FRET), see Fig. A.8 Transfer rates in both directions were 
determined by a FRET assay as described in methods 4.7. Additionally, 
we measured release rates via an independent colorimetric assay that 
works without SUVs and instead provides detergent micelles (sodium- 
cholate) as an acceptor for tocopherols (details in supplementary in-
formation, see p. 27). 
Table A.6 summarizes all the measured rates and Fig. A.9 illustrates 
each completed experiment. Figure A.10 illustrates and Table A.7 
summarizes all results of the ABTS•+ decolorization assay. 
In the colorimetric assay the observed release rate (obskrel) of 
α-tocopherol by native α-TTP is 1.15 × 10− 3 ± 1.27 × 10− 5 s− 1 and of 
γ-tocopherol 3.36 × 10− 3 ± 5.99 × 10− 5 s− 1. The fact that the release 
rate of γ-tocpherol is approximately three-fold higher reflects the lower 
affinity of wild type α-TTP towards γ-trocopherol in relation to 
Fig. 5. (A) Thermodynamic signature of the 
binding of α-tocopherol to α-TTP and of 
γ-tocopherol to γ-TTP, respectively. In both case 
a strong favorable ethalpic contribution (ΔHb) 
exceeds the unfavourable entropic contribution 
( − T⋅ΔSb), resulting in both cases in a negative 
binding free energy ΔGb; and thus in the binding 
of the ligand with a dissociation constant (Kd) at 
36.85 ∘C (310 K) of 14.25 nM for α-TTP/ 
α-tocopherol and of 53.79 nM for γ-TTP/ 
γ-tocopherol, respectively. (B) Illustration of the 
hydrogen bond network within the binding of 
α-TTP. The four trapped water molecules within 
the binding pocket together with residues Y100, 
Y117, S136, S140 V182, L189 and the ligand it-
self make up the large hydrogen bond network 
responsible for the strong ethalpic contribution 
(ΔHb) to the total binding (ΔGb).   
Table 2 
Partitions coefficients Kp of tocopherols for wild type α-TTP and γ-TTP.  
Protein Ligand Kp  ΔKp  
α-TTP α-tocopherol 2.72 ± 0.0  
α-TTP γ-tocopherol 4.05 +1.33 
γ-TTP α-tocopherol 3.08 +0.37 
γ-TTP γ-tocopherol 2.54 − 0.18  
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Fig. 6. The transcytotic efficacy of tetracosameric α-TTPs and γ-TTPs (α-TTP A156L) compared to its monomer form were monitored in a transwell model system 
comprising confluent and maturely developed monolayers of HUVECs. Human transferrin served as the positive control. Simultaneous application of rhodamine 
isothiocyanate - (RITC) labeled dextran confirmed the integrity of the HUVEC cell monolayers and served to determine the paracellular flux. Measurements report a 
10-fold–18-fold increase in the flux through the endothelial cell layer of both α- and γ-TTPs compared to that of RITC-dextran. Our data also show that α- and γ-TTPs 
cross the endothelium at a flux rate 2–6 times faster than human transferrin with increasing speed the more complex the protein assemblies. 
Fig. 7. Primary human umbilical vein 
endothelial cells (HUVECs) were allowed 
to form a tight monolayer within 7 days of 
pre-culturing. At day 7 tocopherol transfer 
proteins (TTPs) carrying either α-tocoph-
erol (α-TTP) or γ-tocopherol (α-TTP 
A156L, referred as γ-TTP) were added for 
4 h followed by cytokine (TNF: 50 ng/ml, 
IL1F2: 1 ng/ml, IFNG: 50 ng/ml) stimula-
tion for another 4 h mRNA levels of IL6 
(A), CCL2 (B), TNF(C), COX2 (D) and 
ICAM1 (E) were significantly increased by 
cytokine stimulation (controls, left boxes) 
while α-TTP significantly reduced 
cytokine-induced mRNA expression of 
both IL6, CCL2, TNF and ICAM1 (central 
boxes). γ-TTP was not able to attenuate 
cytokine-mediated transcription of any 
pro-inflammatory cytokine or protein 
measured (right boxes). Boxplots display 
outliers, if applicable. N = 1 in triplicate. 
Statistical evaluation with R with assumed 
significance at p < 0.05. Relevant signifi-
cant differences are designated with as-
terisks as follows: *p < 0.05, **p < 0.01, 
***p < 0.001.   
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α-tocopherol. In the γ-TTP mutant, the release rate of γ-tocopherol ap-
proximates that of wild type. 
With the rate constants (krel and kseq) measured by FRET as described 
thoroughly in supplementary information (see p. A.1), it is possible to 
estimate the partition coefficient (Kp) of the ligand between the protein 
and the liposome membrane. Kp quantifies the relative preference of the 
ligand between two specific loci, in this case it the binding pocket of TTP 
and its incorporation within a lipid bi-layer Table 2. The more the Kp of 
γ-TTP/γ-tocopherol approximates the partition coefficient of native 
α-TTP/α-tocopherol the better. Importantly, γ-tocopherols partitions 
into γ-TTP with very similar ratio compared to that of α-tocopherol into 
α-TTP. This suggests that γ-TTP can have similar efficiency in the 
extraction of γ-tocopherol from the endosomal compartments than its 
native counterpart. 
2.3. Activity of γ-TTP in cell cultures 
Having demonstrated that γ-TTP maintains very similar binding and 
exchange properties for γ-tocopherol as native α-TTP for α-tocopherol, 
we proceeded to investigate the properties of γ-TTP in cellular cultures 
in vitro. 
2.3.1. Transcytosis of γ-TTP through a HUVEC monolayer 
The native form of tocopherol transfer protein loaded with 
α-tocopherol (α-TTP) was readily transported through a tight endothe-
lial monolayer in our HUVEC culture model as previously described 
[16]. The modified TTP carrying γ-tocopherol displayed similar prop-
erties in vitro as it was also transported through a HUVEC monolayer by a 
transcytotic mechanism (Fig. 6). All monomeric, oligomeric and tetra-
cosahedral forms of γ-TTP were transported to a considerable extent 
(Fig. 6). For α-TTPs, we observed a 10.3-fold (monomeric α-TTP), 
10.4-fold (intermediate α-TTP) and 18.0-fold (α-TTPS) increase in flux 
through the endothelial cell layer compared to that of RITC-dextran, 
which is a marker for unregulated paracellular flux. γ-TTPs showed a 
6.1-fold (monomeric γ-TTP), 16.4-fold (intermediate γ-TTP) and 
18.6-fold (γ-TTPS) increase in flux compared to that of RITC-dextran. 
The faster uptake for the largest TTPS constructs suggests the presence 
of a recognition-mediated mechanism for cell incorporation and trans-
fer, instead of a diffusion-dominated event. 
2.3.2. Monomeric α-TTP attenuates cytokine-induced transcription of pro- 
inflammatory cytokines and proteins 
In a second set of experiments, HUVEC cells were first grown against 
1 ml TTP sample in PBS (control only PBS) and 3 ml HUVEC growth 
media, and then incubated with recombinant human TNF (rhTNF), 
rhIL1F2 and rhIFNG. 
This resulted in a substantial induction of the proinflammatory cy-
tokines IL6, CCL2, and TNF, the inflammation-associated enzyme COX2 
(Fig. 7 A-D, left boxes) and the adhesion molecule ICAM1 (Fig. 7 E, left 
boxes) as mRNA steady state levels increased by 49-427-fold compared 
to untreated controls. The same test was conducted by first soaking the 
HUVEC cells in a 12.5 μM solution of substrate-loaded TTP proteins. In 
particular, we repeated independent tests using solutions of α- or γ-TTP, 
loaded with α-and γ-tocopherol, respectively, in either their monomeric, 
oligomeric, or TTPS protomeric states. Growing primary HUVECs as 
adherent mono-layer prevents transcytosis and thus forces a fraction of 
TTP proteins into the cytoplasmic environment. Strikingly, pre- 
treatment of HUVECs with monomeric α-TTP significantly decreased 
cytokine-induced mRNA levels of IL6, CCL2, TNF and ICAM1 (Fig. 7 A-C, 
E, central boxes). Contrary to α-TTP, monomeric γ-TTP did not coun-
teract cytokine-mediated inflammation in HUVECs. Transcription of IL6, 
CCL2, TNF, COX2 and ICAM1 was not diminished by γ-TTP pre- 
treatment prior to pro-inflammatory cytokine application (Fig. 7 A-E, 
right boxes). Thus, cytokine-mediated increases in mRNA levels of 
selected target genes remained significantly elevated compared to the 
respective control following γ-TTP pre-treatment and was only reduced 
by α-TTP pre-treatments as depicted in Fig. 7. Initial data suggest pu-
tative pro-inflammatory activity of oligomeric TTPs per se, as oligomeric 
α-TTP and γ-TTP each induced considerable cytokine expression in 
HUVECs compared to their respective monomeric proteins. Interest-
ingly, cells treated with α-TTPS demonstrated elevated mRNA levels of 
pro-inflammatory cytokines and adhesion proteins similar to those of 
untreated cells, indicating that TTPS constructs are incompetent for 
ligand release in HUVEC. 
3. Discussion and conclusions 
HUVECs originate from human umbilical veins, representing large 
vessel endothelium that is capable of both responding to and inducing an 
inflammatory environment. In this context, HUVECs have been shown to 
express various toll-like receptors and to secrete cytokines, chemokines 
and adhesion molecules including ICAM1 [27]. Moreover, nicotinamide 
adenine dinucleotide phosphate oxidase (Nox), which is a key player in 
cardiac inflammation and heart failure, is a major producer of reactive 
oxygen species (ROS) in vascular cells, so in HUVECs. In this setting, Nox 
can be readily induced by inflammatory stimuli. Given that the 
Nox-isoforms Nox2 and Nox4 are both expressed in endothelial cells 
[28], application of inflammatory cytokines is assumed to promote the 
formation of cellular ROS. Additionally, TNF induces a 
pro-inflammatory environment in human endothelial cells via COX and 
NOS and disrupts redox homoeostasis [29] accounting for lipid peroxi-
dation and DNA hydroxylation [30]. Applying TNF, IL1F2 and IFNG to 
HUVECs induces inflammation and the release of reactive species (e.g., 
superoxide, hydrogen peroxide, hydroxyl radical) and chemical media-
tors (e.g., cytokines, chemokines, eicosanoids, complement compo-
nents) thereby inducing tissue damage and redox stress [30]. Incubation 
of mature HUVEC monolayers with rhTNF, rhIL1F2 and rhIFNG resulted 
in marked induction of the transcription of the pro-inflammatory cyto-
kines IL6, CCL2, and TNF, the enzyme COX2, which stokes inflammatory 
processes, and the adhesion molecule ICAM1 (Fig. 7) [27]. 
As reported, the in vitro antioxidant activities of the major lipophilic 
tocopherol isomers (α, β, γ, and δ) may depend very much on the test 
system used [10,31]. Furthermore, tocotrienols may represent better 
antioxidants in membrane systems, while tocopherols are better in so-
lution [32]. Interestingly, α-tocopherol preferentially accumulates in 
human tissues and serum irrespective of the genetic background with 
simultaneous discrimination of γ-tocopherol [10,33]. 
As we report (Fig. 6), both monomeric and oligomeric α-TTP and 
γ-TTP are readily taken up by HUVECs, transported to the basolateral 
side and finally secreted (transcytosis). Prior to this study, this had been 
solely shown for α-TTP [16]. Thus, we conclude that γ-TPP not only 
exhibits equivalent biophysical but also physiological properties to 
α-TTP within in vitro cultured cells. As tocopherols are readily released 
intracellularly by TTP constructs, they potentially play a key role in the 
prevention of cellular inflammatory processes as mediated by cytokines 
and ROS. As described in the literature, α-tocopherol is able to reduce 
redox stress in vitro. Therefore, α-tocopherol, intracellularly released 
from α-TTP, may attenuate cytokine-mediated oxidative stress and 
inflammation (Fig. 7). Although γ-TTP was readily taken up by HUVECs, 
γ-TTP had no such effect. Therefore, inflammation was counteracted by 
α-TTP while γ-TTP failed to rescue the endothelium from 
pro-inflammatory stimuli. The transcription factor nuclear factor “kap-
pa-light-chain-enhancer” of activated B-cells (NF-κB) orchestrates the 
transcription of numerous cytokines, amongst others [34]. Importantly, 
not only ligand-dependent induction of signal transduction (e.g. TNF) 
but also intracellular redox homoeostasis are centrally involved in the 
activation of NF-κB [34]. Particularly, hydrogen peroxide has been 
shown to activate NF-κB and antioxidants may block NF-κB activation 
[30,35,36]. Thus, α-tocopherol may have favourably impacted cellular 
redox status, thereby inhibiting NF-κB-dependent pro-inflammatory 
cytokine production. 
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Structural and thermodynamical characterisation of γ-TTP presented 
in this works were meant to verify that γ-TTP shows similar chemical, 
biophysical and physiological properties in vitro, e.g., vitamin release 
and transcytosis, than α-TTP. Thus, the beneficial effect of α-TPP with 
respect to attenuation of inflammatory processes seems to primarily 
depend on the carried tocopherol itself, not the TTP construct. This 
conclusion is supported by recent findings of the research group of Cook- 
Mills, showing a protective association for α-tocopherol but not with 
γ-tocopherol in asthma inception in a human cohort study [37]. 
In this work we have sought to provide the most comprehensive 
characterisation of the γ-tocopherol-specific γ-TTP mutant. This in-
cludes the solution of its crystal structure, the analysis of its transfer 
activity through partition coefficients (Kp), as well as the determination 
of its affinity through complementary dissociation constants. These 
measurements collectively represent a robust quantitative in vitro 
characterisation of γ-TTP’s functionality. The release vs. sequestration 
ratio of both wild type α-TTP and γ-TTP for each respective tocopherol is 
of highest importance for rigorous analysis of transfer activity, see 
Table A.6. We report that the magnitude of the related ratio for both TTP 
variants broadly remains in the same range. Kp represents a powerful 
tool for the analysis of transfer activity, allowing for the estimation of 
overall transfer protein functionality. Kp is the quotient between the 
respective transfer rates as described by equation (2). Using equation (2) 
we were able to normalize to the sequestration rate. Hence, Kp values 
capture the relative increase in release or simply the normalized general 
release velocity. In this study the observed decrease from 2.72 to 4.05 in 
the Kp when comparing wild type α-TTP - α-tocopherol with wild type 
α-TTP - γ-tocopherol indicates a significant loss of functionality. In 
counterpoint, the determined value of 2.54 for γ-TTP - γ-tocopherol 
indicates full functionality. 
The crystal structure of γ-TTP complexed with γ-tocopherol revealed 
that the substitution of leucine by alanine at position 156 fomented 
compensatory effects that favor the binding of γ-tocopherol. Accord-
ingly, a low discrepancy of only 0.019 Å for the van der Waals (vdW) 
contacts between the carbon of A156 to C8 of α-tocopherol (4.498 Å) 
and the δ1-carbon of L156 to C2 of γ-tocopherol (4.479 Å) was observed. 
Moreover, in the wild type structure I154 creates a vdW contact (3.701 
Å) between its δ1-carbon and C8 of α-tocopherol, whereas in the mutant 
the binding occurs to position C2 of γ-tocopherol (4.515 Å). The related 
extension of 0.811 Å of the vdW contact proved disadvantageous and 
may well contribute to the lower affinity of the mutant type bound to 
γ-tocopherol compared to the wild type bound to α-tocopherol. The 
extension may partially be compensated by a shortening of 1.696 Å of 
the vdW contact between the δ1-carbon of L156 and C10 of γ-tocoph-
erol. Other amino-acid residues and the phytyl chain of the ligand were 
barely shifted as illustrated in Fig. 2C. We conclude that the niche 
composed by I194, V191, I154, and L183 around C8 of α-tocopherol in 
the binding pocket of native α-TTP forms a network of hydrophobic 
interactions each of which is near its optimal van der Waals distances. 
Moreover, in the atomic model of γ-TTP + γ-tocopherol we observe 
that the mutation A156L partially reestablishes this optimal distance 
network. However, we noted that the average distance to γ-tocopherol 
was prolonged and therefore off the optimal rm distance. Therefore, the 
A156L γ-TTP mutation tolerates the binding of γ-tocopherol but may not 
necessarily increase the dissociation constant (Kd) of wild type TTP for 
this ligand. In previous experimental work, we calculated in silico and 
derived the relative binding free energy (ΔΔGb) between RRR- 
γ-tocopherol and RRR-α-tocopherol bound to α-TTP A156L. There we 
observed that γ-TTP binds preferentially RRR-γ-tocopherol by a calcu-
lated ΔΔGb of − 1.19±2.28 kcal mol− 1, and an experimental ΔΔGb of 
− 3.42±3.04 kcal mol− 1 [18]. Here we have reapplied that approach 
leading to the determination of the absolute binding free energy of γ-TTP 
to γ-tocopherol. mDSC was applied because, in contrast to punctual 
isothermal calorimetry, it offers relatively precise monitoring of the 
dissociation constant over a range of temperatures. Both methods do 
however allow for the determination of the contributing enthalpic and 
entropic terms to the binding free energy ΔGb. We determined a Kd for 
α-tocopherol bound to wild type α-TTP of 14.25 nM at 36.85∘C, which is 
comparable to previously reported values of 25 nM [38] and 9.8 nM 
[24], respectively. The discrepancies arise from the fact that it may be 
difficult to precisely determine the working temperature in classical 
assays, for example we observed a Kd of 25 nm at approximately 40.35∘C 
(313.5 k) and of 9.8 nM at 34.35∘C (307.5 K). For γ-TTP and γ-tocopherol 
we determined a Kd of 53.79 nM at 36.85∘C (310 K), which is 3.8 times 
lower than the reference value for α-TTP and α-tocopherol. However, 
this value still remains within the acknowledged functional range. We 
conclude that the observed preference for γ-tocopherol and the 
impressive small ΔKp of 0.18 between γ-TTP/γ-tocopherol and 
α-TTP/α-tocopherol both indicate that γ-TTP may act as a functional 
substitute for wild type α-TTP. Since both α-TTP and γ-TTP exhibit 
equivalent biophysical but also physiological properties within in vitro 
cultured cells, the beneficial effect of α-TPP for physiology seems to 
primarily depend on the carried tocopherol itself, not the TTP construct. 
This conclusion is fully supported by recent findings of the research 
group of Cook-Mills, showing a protective association for α-tocopherol 
but not with γ-tocopherol in asthma inception in a human cohort study 
[37]. 
Building on these findings, a natural future step will be testing our 
conceptual framework in an in vivo context by expanding current 
research towards the use of a γ-TTP knock-in mouse model that may 
exhibit modifications in phenotype and thereby provide clues about how 
the homeostasis of tocopherols is associated with their physiologic 
functions. 
4. Material and methods 
4.1. Expression and purification 
TTP Proteins were expressed in Escherichia coli strain BL21(DE3) and 
purified essentially as previously described [16,18]. 
4.2. Preparation of TTP ligand-complexes 
Protein-ligand complex formation was induced by dialysing freshly 
prepared apo-TTP in the presence of detergent solubilized tocopherol. In 
brief, a droplet of 1 mg of α- or γ-tocopherol was overlaid with 40.9 mg 
of solid sodium cholate and subsequently suspended in 1 ml of elution 
buffer (20 mM Tris, 100 mM NaCl, 150 mM imidazole, pH 8.0). The 
suspension was bath sonicated until all material had dissolved to a clear 
solution. Apo-α-TTP (11 ml at ≤ 2.5 mg/ml) was complemented with the 
tocopherol-sodium cholate solution at 9:1 (v/v) ratio and transferred 
into a CelluSep T3 dialysis tubular membrane with an MWCO range of 
12–14 kDa (Membranes Filtration Products. TX, USA). Dialysis was 
performed in two steps against 3 l buffer (20 mM Tris, 100 mM NaCl, pH 
8.0) each for 6 h at 4∘C. The dialysate (12 ml) was filtered through a 
Millex GP 0.22 μm filter (EMD Milipore, MA, USA), supplemented with 
Triton X-100 at a final concentration of 0.01% (v/v), reduced to 2 ml and 
separated by preparative gel filtration chromatography (GFC). Fractions 
corresponding to the size of the monomeric TTP ligand-complex were 
pooled and concentrated to 20 mg/ml using Vivaspin concentrators 
(MWCO 10 kDa; Satorius, Göttingen, Germany) and directly used for 
crystallization. Fractions corresponding to the size of α- or γ-TTPS nano- 
spheres were pooled and concentrated using Vivaspin concentrators 
(MWCO 30 kDa) to 10 mg/ml re-purified by analytical GFC. 
4.3. Crystallization and structure determination of γ-TTP 
Crystals were grown by either hanging or sitting-drop vapor diffu-
sion using reservoir solutions ranging from 10 to 15% PEG-4000, 
100–175 mM ammonium sulfate in 100 mM 4-(2-hydroxyethyl)-1- 
piperazineethanesulfonic acid (Hepes) sodium pH 7.5 at 18∘C. Freshly 
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prepared monomeric γ-TTP ligand-complex was used in a concentration 
range between 12 and 22 mg/ml. Highest quality crystals of fully 
reduced γ-TTPS were observed within two weeks at drop ratios of pro-
tein over reservoir ranging between 3/1 and 2/1 (v/v). Crystals had 
cubic shape with edge length ranging between 20 and 80 μm. Isomor-
phous crystals of fully oxidized γ-TTPS were collected after two months. 
All crystals were flash frozen in nitrogen after adding glycerol in two 
steps to a final concentration of 20% (v/v). Diffraction data were 
collected at the Swiss Light Source (SLS) synchrotron beamline X06DA 
(PSI Villigen) at 100 K, employing a Dectris Pilatus 2 M CCD detector 
(DECTRIS Ltd., Baden, Switzerland). All data were indexed, integrated 
and scaled with XDS [39]. Phaser-MR was used for calculating the initial 
phases with the truncated structure model (residues 47–275) of mono-
meric α-TTP (PDB ID: 1OIP) as search structure. The atomic model 
γ-TTPS was refined by iterative cycles of manual model building using 
COOT [40] and restrained refinements using the Phenix program suite 
[41]. Coordinates and structure factors of the structure has been 
deposited in the RCSB Protein Data Bank with ID code 6ZPD. 
4.4. Size exclusion chromatography 
Preparative and analytical GFC of monomeric TTP and tetracosa-
meric TTPS was performed on HiLoad 16/60 Supersose 75 prep grade 
and on Superose 6 10/300 columns respectively (GE Healthcare, Little 
Chalfont, UK), both attached to an ÄKTA Purifier chromatography sys-
tem (GE Healthcare, Little Chalfont, UK). Runs were performed in SEC 
buffer (10 mM Tris, 100 mM NaCl, pH 8.0) at flow rates ranging from 0.5 
(analytical) to 1.5 ml/min (preparative) at 6 ∘C. Both SEC columns were 
calibrated using commercially available protein calibration kits (GE 
Healthcare, Little Chalfont, UK). 
4.5. Micro-differential scanning calorimetry 
Micro-differential scanning calorimetry (mDSC) was performed on a 
TA Instruments Nano DSC calorimeter running Nano DSCRun Software 
v4.2.4 (TA Instruments, DE, USA). Each DSC experiment required 300 μl 
of protein sample as well as the same volume of reference buffer (20 mM 
TRIS-HCL, 40 mM NaCl, pH 7.4). Protein samples were measured in 
duplicate and the concentration of protein samples was determined by 
amino acid analysis in order to gather exact knowledge of protein 
quantities applied to the DSC experiments. Protein concentration ranged 
from 0.3846 to 0.5713 mg ml− 1. Each sample was centrifuged at 13,200 
rpm for 10 min at 4 ∘C and degassed for 5 min prior to DSC experiments. 
Reference buffer was used to generate the baselines that were subtracted 
from the sample to generate the DSC thermograms, which were ana-
lysed. Data were collected under 3 bar pressure from 20 to 80 ∘C using a 
2 K min− 1 temperature increment with a 10-min equilibration period 
prior to the scans. Raw data processing and visualization was performed 
with NanoAnalyze Software v3.1.2 (TA Instruments, DE, USA). The 
calorimeric enthalpy of unfolding (ΔHu) was calculated by integrating 
the Cp versus T curve using a sigmoidal baseline with 1st order fit for the 
initial as well as for the final baseline. The difference in the heat capacity 
of unfolding ΔCUp was determined by quantifying the difference of heat 
capacity between the pre-translational inflexion point before the endo-
thermic peak and the post-translational inflexion point after the endo-
thermic peak. 
The contribution to the enthalpy and entropy at the temperature is 
described by equations (4) and (5). 
ΔHu(T)=ΔHu(Tm) + ΔCp(T − Tm) (4)  
ΔSu(T)=ΔSu(Tm) + ΔCpln
T
Tm
(5)  
4.6. Preparation of SUVs 
Acceptor small unilamellar liposome vesicles (SUVs) were prepared 
by mixing stocks of phosphatidylcholine (Sigma-Aldrich, MO, USA), 
dansyl-DHPE (Avanti Polar Lipids, AL, USA), BHT (Sigma-Aldrich, MO, 
USA) and tocopherol (DSM, Kaiseraugst, Switzerland) in chloroform as 
described in Table 3. Donor SUVs that were used to determine the return 
transfer (sequestration of tocopherol by apo-α-TTP), additionally con-
tained a 25% mole fraction of tocopherol which resulted in a strong 
FRET signal as shown in Fig. A.8 B. The mixtures were dried under a 
stream of nitrogen, then 2 ml of HBS buffer (100 mM NaCl, 20 mM 
HEPES/NaOH pH 7.5 and 0.02% sodium azide) were added and the 
mixture was incubated for 15 min at room temperature. The mixture was 
subsequently vortexed vigorously in order to resuspend all the phos-
pholipids (PLs), the result was a cloudy uniform suspension. The PLs 
suspension was then sonicated in a bath sonicator twice for 5 min and 
afterwards ten freeze-thaw cycles were performed until the suspension 
got almost transparent, however, a slight opalescence was still 
noticeable. 
4.7. Transfer rate measurements 
The transfer rates of vitamin E were determined by monitoring the 
time dependent change in the FRET signal of a sample upon mixing holo- 
TTP with acceptor-SUVs and apo-TTP with donor-SUVs, respectively. In 
order to reliably monitor the kinetics an injector was used to mix the 
solutions of both reactants and the time dependent FRET signal was 
measured at every second with an Infinite M1000 Pro fluorescence plate 
reader (TECAN, Männedorf, Switzerland). The excitation was set at 292 
nm (10 nm slit) and the emission at 525 nm (20 nm) slit, the gain was 
kept manually in every measurement at 100. Kinetics measurements 
were performed always at 37 ∘C (310.15 K) so that physiological con-
ditions were simulated. The fluorescence signal was normalized to the 
starting fluorescent intensity of tocopherol bound to TTP or of tocoph-
erol bound to SUVs as 100%, respectively. It results that the rate law of 
the transfer for both directions is of second-order, which explains the 
reason for dimensionless of the partition coefficient (Kp). However, in 
this case we obtained pseudo first-order transfer rates for both reactions 
by fitting the fluorescence data to the sum of a single exponential process 
and a linear term (representing chromophore bleaching). Equation (6) 
was used to quantify the sequestration rate (kseq) of tocopherol from 
SUVs to apo-α-TTP, and equation (7) was used to quantify the release 
rate (krel) of tocopherol from holo-α-TTP to SUVs. 
Single exponential equation for kseq and linear term for bleaching 
Ft =F0e− kseq t − (mt+A0) (6) 
Single exponential equation for krel and linear term for bleaching 
Ft =F0
(
1 − e− krel t
)
− (mt+A0) (7)  
4.7.1. Quantifying the release of tocopherol with sodium cholate micelles 
ABTS was dissolved in water (7 mM) and incubated overnight in 
presence of 2.45 mM potassium persulfate (final concentration), in order 
to form ABTS•+ radicals. Vitamin E bound to TTP (end concentration 
6.4 μM) is not accessible to the ABTS•+ radical (end concentration 8 μM) 
and hence no decolorization was observed without the presence of 
negatively charged acceptor micelles. Decolorization was observed at 
734 nm with an Evolution Array UV/VIS (Thermo Fisher Scientific, MA, 
Table 3 
SUV composition overview.  
Lipids Ratios Type 
(60%) PC/dansyl-DHPE/BHT  98.5/1/0.5 Acceptor SUV 
(60%) PC/dansyl-DHPE/BHT/TOCs  78.5/1/0.5/20 Donor SUV  
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USA) upon addition of sodium cholate micelles to an end concentration 
of 17 mM. Since the quenching reaction of the radical is immediate one 
can deduce that the decolorization kinetics refers to the release kinetics 
of vitamin E from holo-α-TTP. Because the concentration of sodium 
cholate is in great excess (2656.25-fold) compared to holo-α-TTP one 
can use a pseudo-first-order approximation for the calculation of release 
rates. Thus, equation (8) shows the reaction mechanism for the release 
of tocopherol in this assay and equation (9) the resulting rate equation. 
[PL][M]⇌[P][ML]if [M]≫ [PL]
→[PL]→[P][ML]
(8) 
The rate equation (9) is transformed as illustrated above from a 
second order reaction to pseudo-first-order reaction. Due to the simpli-
fication of the reaction equation (8), it is easy to integrate and linearize 
the rate equation for obskrel as shown by equation (10). 
r = −
d[PL]
dt
= krelPL
]
M
]
= obskrelPL
]
,where obskrel = krel[M]0 (9)  
ln
[PL]t
[PL]0
= − obskrelt (10)  
4.8. Cell culture 
Primary human umbilical vein endothelial cells (HUVECs) were 
isolated from fresh umbilical cords with the help of trypsin/EDTA as 
described previously [16]. HUVECs were maintained in Endothelial Cell 
Growth Medium (Promocell, Heidelberg, Germany) comprising 100 
U/ml penicillin and 100 μg/ml streptomycin (PAN Biotech, Aidenbach, 
Germany) with gelatin pre-coating (Sigma-Aldrich, Darmstadt, Ger-
many). For subculturing, cells were detached with Trypsin/EDTA 
(0.04%/0.03%) using the DetachKit for primary human cells from Pro-
mocell. To comparatively determine transcytosis of the tocopherol 
transfer proteins (TTPs) that carry α-tocopherol (α-TTP) and γ-tocoph-
erol (α-TTP A156L, referred as γ-TTP), HUVECs were cultured in a 
transwell system as described before [16]. In brief, cells were allowed to 
form a tight monolayer within 7 days of culture while medium was 
changed every other day. For transcytosis measurements medium 
comprising RITC labeled dextran (70 kDa; marker for paracellular flux) 
and either 0.4 mg/ml of FITC labeled monomeric, oligomeric or spher-
ical α-TTP or γ-TTP, respectively, was applied to the apical chamber. 
Transferrin served as the positive control. Transport was monitored by 
sampling 100 μl of basolateral medium at consecutive time points (15, 
30, 45, 60, 120, 180, and 240 min) after addition of TTPs to the apical 
chamber. Basolateral aliquots were subsequently analysed for fluores-
cence with a Tecan infinite200 microplate reader (Tecan Deutschland 
GmbH, Crailsheim, Germany) at an excitation wavelength of 485 nm 
and an emission wavelength of 535 nm (FITC) followed by measure-
ments at an excitation wavelength of 535 nm and an emission wave-
length of 590 nm (RITC). For the determination of mRNA levels of 
selected pro-inflammatory cytokines and proteins, cells were seeded in 
gelatin pre-coated standard 6-well multiwell plates (Sarstedt, Nuem-
brecht, Germany). Cells were allowed to form a tight monolayer within 7 
days of culture while medium was changed every other day. Then 
monomeric TTPs loaded with either α-tocopherol (α-TTP) or γ-tocoph-
erol (γ-TTP; 0.4 mg/ml, each) were applied for 4 h, respectively. Ca and 
Mg free phosphate buffered saline (PBS; PAN Biotech) was used for 
controls. Then cell were treated with a cytokine mix consisting of human 
recombinant (rh) tumor necrosis factor alpha (rhTNF, 50 ng/ml), 
interleukin-1 beta (rhIL1F2, 1 ng/ml) and interferon-gamma (rhIFNG, 
50 ng/ml; all ImmunoTools GmbH, Friesoythe, Germany) for another 4 
h. Cells were washed with PBS, covered with TriFast reagent (peqlab, 
Erlangen, Germany) and stored at 80 ∘C until RNA isolation. 
4.8.1. RT-qPCR analysis 
Total RNA was extracted with TriFast reagent according to the 
manufacturer’s instructions. RNA concentration was determined via 
NanoDrop measurements (NanoDrop2000c; ThermoScientific, Wal-
tham, MA/USA). RT-qPCR was performed using a SensiFast SYBR No- 
ROX One-Step Kit (Bioline, London, UK) on a Rotor-Gene 6000 real- 
time PCR cycler (Corbett/Qiagen). DNA primer were purchased from 
Eurofins Genomics (Ebersberg, Germany). Relative mRNA concentra-
tions were calculated using the respective standard curves. Target gene 
expression (Table 4) was normalized to the expression of the house-
keeping genes glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
and hypoxanthine-phospho-ribosyl-transferase 1 (HPRT1). 
4.8.2. Statistical analysis 
Statistical analyses on cell culture data were performed using the 
statistical software R version 3.6.0 [42]. The data evaluation started 
with the definition of an appropriate statistical model based on gener-
alized least squares taking heteroscedasticity in consideration [43]. The 
model included comparisons concerning presence or absence of cyto-
kines and treatment with the respective type of TTP versus control as 
well as their interaction term as fixed factors. The donor of HUVECs was 
regarded as random factor. The residuals were assumed to be normally 
distributed and to be heteroscedastic with respect to the different levels 
of cytokines and type of proteins. These assumptions are based on a 
graphical residual analysis. Based on this model, a Pseudo R2 was 
calculated [44] and an analysis of variances (ANOVA) was conducted, 
followed by multiple contrast tests [45,46] in order to compare the 
several levels of the influence factors as described above, respectively. 
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